Expert consensus on the clinical application of the markers of hepatitis B virus / 中华肝脏病杂志
Chinese Journal of Hepatology
;
(12): 389-400, 2023.
Article
in Chinese
| WPRIM
| ID: wpr-981866
ABSTRACT
Hepatitis B virus biomarkers are mainly used in clinical practice to diagnose infection, monitor disease progression, evaluate response to chronic hepatitis B treatment, and evaluate the efficacy of novel antiviral drugs in clinical trials. In combination with the recent research progress of antiviral therapy for chronic hepatitis B and the actual needs of clinical diagnosis and treatment, the expert consensus was formulated by the Cooperative Group of Basic Research and Experimental Diagnosis of Liver Diseases, Chinese Society of Hepatology, Chinese Medical Association. It summarized the evidence and recommended the key points for the clinical application of classic and novel hepatitis B virus related biomarkers in order to guide the standardized and reasonable clinical application for these biomarkers.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Antiviral Agents
/
Biomarkers
/
Hepatitis B virus
/
Hepatitis B, Chronic
/
Consensus
/
Hepatitis B
Limits:
Humans
Language:
Chinese
Journal:
Chinese Journal of Hepatology
Year:
2023
Type:
Article
Similar
MEDLINE
...
LILACS
LIS